» Articles » PMID: 37286600

Heritable Transcriptional Defects from Aberrations of Nuclear Architecture

Overview
Journal Nature
Specialty Science
Date 2023 Jun 7
PMID 37286600
Authors
Affiliations
Soon will be listed here.
Abstract

Transcriptional heterogeneity due to plasticity of the epigenetic state of chromatin contributes to tumour evolution, metastasis and drug resistance. However, the mechanisms that cause this epigenetic variation are incompletely understood. Here we identify micronuclei and chromosome bridges, aberrations in the nucleus common in cancer, as sources of heritable transcriptional suppression. Using a combination of approaches, including long-term live-cell imaging and same-cell single-cell RNA sequencing (Look-Seq2), we identified reductions in gene expression in chromosomes from micronuclei. With heterogeneous penetrance, these changes in gene expression can be heritable even after the chromosome from the micronucleus has been re-incorporated into a normal daughter cell nucleus. Concomitantly, micronuclear chromosomes acquire aberrant epigenetic chromatin marks. These defects may persist as variably reduced chromatin accessibility and reduced gene expression after clonal expansion from single cells. Persistent transcriptional repression is strongly associated with, and may be explained by, markedly long-lived DNA damage. Epigenetic alterations in transcription may therefore be inherently coupled to chromosomal instability and aberrations in nuclear architecture.

Citing Articles

Propagation of neuronal micronuclei regulates microglial characteristics.

Yano S, Asami N, Kishi Y, Takeda I, Kubotani H, Hattori Y Nat Neurosci. 2025; 28(3):487-498.

PMID: 39825140 DOI: 10.1038/s41593-024-01863-5.


Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation.

Black E, Ramirez Parrado C, Trier I, Li W, Joo Y, Pichurin J Nat Commun. 2024; 15(1):10782.

PMID: 39737931 PMC: 11685634. DOI: 10.1038/s41467-024-54922-7.


The triple code model for advancing research in rare and undiagnosed diseases beyond the base pairs.

Lomberk G, Urrutia R Epigenomics. 2024; 17(2):115-124.

PMID: 39630027 PMC: 11792834. DOI: 10.1080/17501911.2024.2436837.


When do the pathological signs become evident? Study of human mesenchymal stem cells in MDPL syndrome.

Paola S, Lara G, Michela M, Silvia D, Serena M, Rosalba P Aging (Albany NY). 2024; 16(22):13505-13525.

PMID: 39611849 PMC: 11723661. DOI: 10.18632/aging.206159.


Epigenomic heterogeneity as a source of tumour evolution.

Laisne M, Lupien M, Vallot C Nat Rev Cancer. 2024; 25(1):7-26.

PMID: 39414948 DOI: 10.1038/s41568-024-00757-9.


References
1.
Feinberg A, Koldobskiy M, Gondor A . Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016; 17(5):284-99. PMC: 4888057. DOI: 10.1038/nrg.2016.13. View

2.
Zink D, Fischer A, Nickerson J . Nuclear structure in cancer cells. Nat Rev Cancer. 2004; 4(9):677-87. DOI: 10.1038/nrc1430. View

3.
Maciejowski J, Hatch E . Nuclear Membrane Rupture and Its Consequences. Annu Rev Cell Dev Biol. 2020; 36:85-114. PMC: 8191142. DOI: 10.1146/annurev-cellbio-020520-120627. View

4.
Zhang C, Spektor A, Cornils H, Francis J, Jackson E, Liu S . Chromothripsis from DNA damage in micronuclei. Nature. 2015; 522(7555):179-84. PMC: 4742237. DOI: 10.1038/nature14493. View

5.
Maciejowski J, Li Y, Bosco N, Campbell P, de Lange T . Chromothripsis and Kataegis Induced by Telomere Crisis. Cell. 2015; 163(7):1641-54. PMC: 4687025. DOI: 10.1016/j.cell.2015.11.054. View